Sort
21,453 grants matching “tuberculosis”
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$735,387Kenner Rice · National Institute On Drug Abuse · ZIA · FY2018 · DA
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
$735,318Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Human-centered Design and Communities of Practice to Improve Delivery of Home-based TB Contact Investigation in Uganda
$735,214John Lucian Davis · Yale University · R01 · FY2020 · AI
Unraveling the molecular mechanisms of innate immune memory in humans
$735,078Luis Bruno Barreiro · University Of Chicago · R01 · FY2025 · AI
Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET Imaging
$735,031Sanjay Jain · Johns Hopkins University · R01 · FY2022 · AI
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$734,965Thomas Dick · Hackensack University Medical Center · U19 · FY2022 · AI
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$734,964Thomas Dick · Hackensack University Medical Center · U19 · FY2020 · AI
Childhood infection and prevention of obesity
$734,798Julie Parsonnet · Stanford University · R01 · FY2012 · HD
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages
$734,719Nevan J Krogan · University Of California, San Francisco · R01 · FY2018 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$734,665Shabaana A. Khader · Washington University · R01 · FY2020 · AI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$734,575Shabaana A. Khader · Washington University · R01 · FY2017 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM FUNDING
$734,378Barry Dickman · Philadelphia Departmentof Public Health · U52 · FY2013 · PS
Targeting Membrane Transport Steps in Cell Envelope Assembly
$734,361Daniel E Kahne · Harvard University · R01 · FY2021 · AI
Targeting Membrane Transport Steps in Cell Envelope Assembly
$734,361Daniel E Kahne · Harvard University · R01 · FY2020 · AI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
$734,343James C M Brust · Albert Einstein College Of Medicine · R01 · FY2019 · AI
International HIV-associated Opportunistic Pneumonias (IHOP) Study
$734,306Laurence Huang · University Of California, San Francisco · R01 · FY2009 · HL
Personalized Antimicrobial Combinations to Combat Resistance
$734,122Vincent H Tam · University Of Houston · R01 · FY2020 · AI
Discovery and validation of drug resistance mutations
$734,112Eric H. Rubin · Harvard Medical School · U19 · FY2017 · AI
Project 2: Essential metabolic objectives of M. tuberculosis aerobiology
$733,931Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$733,919Thomas Dick · Hackensack University Medical Center · U19 · FY2019 · AI
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
$733,901David J. Horne · University Of Washington · R01 · FY2022 · AI
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
$733,610Klaus J Frueh · Oregon Health & Science University · R01 · FY2018 · AI
Molecular Imaging for Pulmonary Infections and Inflammation
$733,500Sanjay Jain · Johns Hopkins University · R01 · FY2016 · HL
Human T cell responses permissive for progression to active TB disease
$733,484Joel D. Ernst · Emory University · U19 · FY2015 · AI
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$733,469Myron E Essex · Harvard School Of Public Health · R01 · FY2008 · AI